ImmunityBio
IBRX
HK$22.00
Share price
-4.71%
Change (1 day)
-50.79%
Change (1 year)
Categories
Revenue for ImmunityBio (IBRX)
Revenue in 2024 (TTM): HK$0.11 Billion
According to ImmunityBio's latest financial reports the company's current revenue (TTM 
) is HK$0.11 Billion. an increase over the revenue in the year 2023 that were of HK$4.85 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for ImmunityBio from 2020 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | HK$0.11 B | 2256.45% |
| 2023 | HK$4.85 M | 159.06% |
| 2022 | HK$1.87 M | -74.25% |
| 2021 | HK$7.28 M | 55.28% |
| 2020 | HK$4.69 M |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 | N/A | N/A | 🇺🇸 USA |